Impact of a Multidisciplinary Assessment in Day Hospitalization Versus Standard Care on the Deployment of Supportive Oncology Care Recommended by the Personalized Post-cancer Plan in Patients at the End of Initial Treatment for Gynecological Ovarian and Endometrial Cancer Endometrial Cancer
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This project proposes a structuring of supportive oncology care for the recovery phase after gynecological cancer (ovarian/trope/peritoneum or endometrium). Patients will be divided into three groups based on the identification of oncological support care needs. Patients with supportive oncology care needs will be randomized into two groups: the experimental group, receiving a personalized post-cancer plan with a multidisciplinary assessment of supportive oncology care needs in a day hospital and coordinated follow-up by the referring study nurse, and the control group, receiving a personalized post-cancer plan without a day hospital. Randomization will be stratified according to tumor location (ovary vs. endometrium), use of supportive oncology care during treatment, and treatment center. Patients with no need for supportive oncology care will be followed in an observational cohort. The main objective is to identify and manage the supportive oncology care needs of patients in remission from endometrial or ovarian cancer to improve their quality of life and post-treatment follow-up. A medico-economic analysis will be performed.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Pacjentka ma więcej niż 18 lat.
- •Pacjentka jest w remisji po pierwszym leczeniu raka jajnika lub macicy.
- •Pacjentka zakończyła główne leczenie (terapia podtrzymująca jest dopuszczalna).
- •Pacjentka płynnie mówi po francusku.
- •Pacjentka ma dostęp do telefonu.
- •Pacjentka jest ubezpieczona w ramach systemu opieki społecznej.
- •Pacjentka wyraziła zgodę na udział w badaniu.
✗ Disqualifies
- •Pacjentka ma inne problemy zdrowotne lub psychiczne, które mogłyby utrudnić udział w badaniu.
- •Pacjentka ma nawrót choroby (lokalny lub z przerzutami).
- •Pacjentka przebywa w więzieniu, jest pod kuratelą lub opieką prawną.
- •Pacjentka jednocześnie bierze udział w innym eksperymentalnym leczeniu.
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- September 24, 2026
- Sex
- Female only
Therapies / drugs in trial
Locations (13)
CHU, Besançon
Besançon, France
François Baclesse
Caen, France
Centre Jean Perrin
Clermont-Ferrand, France
Centre Léon Bérard
Lyon, France
Hopital Diaconesses Croix Saint-Simon
Paris, France
Hopital Europeen George Pompidou
Paris, France
Hôpital COCHIN
Paris, France
Institut Curie
Paris, France
Hopital privé des Côtes d'Armor
Plérin, France
Institut Curie, St Cloud
Saint-Cloud, France
CHU, Saint Etienne
Saint-Etienne, France
CHU
Strasbourg, France
Gustave Roussy
Villejuif, France
Trial contact
Florence JOLY, Prof
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 9/25/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.